Chrysin Encapsulated Copper Nanoparticles with Low Dose of Gamma Radiation Elicit Tumor Cell Death Through p38 MAPK/NF-κB Pathways

Improving radiation effect on tumor cells using radiosensitizers is gaining traction for improving chemoradiotherapy. This study aimed to evaluate copper nanoparticles (CuNPs) synthesized using chrysin as radiosensitizer with γ-radiation on biochemical and histopathological approaches in mice bearing Ehrlich solid tumor. CuNPs were characterized with irregular round sharp shape with size range of 21.19–70.79 nm and plasmon absorption at 273 nm. In vitro study on MCF-7 cells detected cytotoxic effect of CuNPs with IC50 of 57.2 ± 3.1 μg. In vivo study was performed on mice transplanted with Ehrlich solid tumor (EC). Mice were injected with CuNPs (0.67 mg/kg body weight) and/or exposed to low dose of gamma radiation (0.5 Gy). EC mice exposed to combined treatment of CuNPs and radiation showed a marked reduction in tumor volume, ALT and CAT, creatinine, calcium, and GSH, along with elevation in MDA, caspase-3 in parallel with inhibition of NF-κB, p38 MAPK, and cyclin D1 gene expression. Comparing histopathological findings of treatment groups ends that combined treatment was of higher efficacy, showing tumor tissue regression and increase in apoptotic cells. In conclusion, CuNPs with a low dose of gamma radiation showed more powerful ability for tumor suppression via promoting oxidative state, stimulating apoptosis, and inhibiting proliferation pathway through p38MAPK/NF-κB and cyclinD1.


Introduction
Cancer is the second main reason of death worldwide, which is considered a substantial challenge affecting human communities [1].Ehrlich solid tumors have been widely used as transplantable models in many investigations due to their contributions to different cancer therapy studies, such as easy examination and investigation of the anticarcinogenic effects of various chemical materials on them [2].Traditional treatment ways such as chemotherapy have shown various critical and damaging side effects that have adversely affected the patient's life.In this regard, cancer therapy strategies face many different challenges to offer selective, effective, and safe methods for cancer treatment in order to improve a patient's life [3].
Radiotherapy (RT) has been utilized in cancer treatment by over 50% of cancer patients during their therapeutic protocol [4].Radiotherapy involves applying high doses of radiation, 40-60 Gy given as fractionated doses, in order to destroy cancer cells and shrink tumor volume [5].Radiotherapy use is limited for many problems, including its harmful effect on nearby healthy tissues [6,7] and radio resistance evolved by many types of malignancies.Some researchers suggested that autophagy could be a potential mechanism for radiosensitization by which cells may protect themselves from ionizing radiation, skipping cell apoptosis, and continuing cell survival, which can remove impaired macromolecules and organelles (e.g., mitochondria) from cells [8].Chemotherapeutic therapies have been shown to be greater effective when low dose of gamma radiation is used [9].Low-dose ionizing radiation exposure was found to reduce tumor tissue formation in both experimental animals and humans [10].In other words, exposure to low dose of gamma radiation is able to inhibit tumor cell progression in Ehrlich tumor-bearing mice [11]via deactivating JAK1/ STAT3 pathway.According to several in vitro studies, low dose of ionizing radiation exposure stimulates p53 pathway, cell cycle arrest, apoptosis, immune system enhancement, etc. [12].Furthermore, improving RT with low doses could be an innovative way to improve RT and other cancer treatment strategies against tumor radio resistance [13].The dose range of 0.3-0.7 Gy may induce anti-inflammatory effects and secretion of the anti-inflammatory cytokine TGF-β1 [14].In addition, starting at a dose of 0.5 Gy, proliferation and expression of receptor activator of NF-kB ligand (RANK-L) in fibroblast-like synoviocytes decreased [15].
Radiosensitizers are chemicals or pharmacological substances that can boost tumor cell death by speeding DNA damage and indirectly creating free radicals; at the same time, it is of a lower effect on normal tissues in most cases [16].
Within the last 2 decades, the exponential increase in published papers that have dealt with the use of chemotherapeutic-based nanoparticles (NPs) for cancer treatment indicates the promising prospects of nanotechnology in improved clinical cancer management.Outstandingly, nanotechnology provides a new approach to synthesizing new metal-containing anticancer agents.Recently and because of the medical importance of nanoparticles, they have been synthesized biologically via eco-friendly, cost-effective methods using microorganisms, enzymes, fungus, and plants or plant extracts [17].
Nanoparticles are applied to enhance the effectiveness of radiotherapy for their excellent physical and chemical characteristics, including good biocompatibility, inherent radiosensitization activity, high drug loading, improved tumor tissue permeability, and retention effects [18].Nanosensitizers acquired many advantages for radiation dose accumulation and radiation effects enhancement, thereby improving the efficacy of radiotherapy, also increase tumor sensitivity to radiation through reactive oxygen species (ROS) [19].Among many radiosensitizers, metal-based nano-radiosensitizers have been the most researched.Nanoparticles containing high-Z elements such as Au NPs, Ag NPs, Pt NPs, Bi2S3, Bi2Se3, WS2, and HfO2 have been used as nano-radiosensitizers.High-Z elements have a high radiation absorption ability and may work as radiosensitizers, which absorb more radiation energy than soft tissues and deposit it within tumors throughout the irradiation process, resulting in more damage in tumor cells alone [20].Worth to mention that radiosensitizers of CuO nanoparticles exhibited the highest DNA damage effect with irradiation [21].
Copper (Cu) is a vital trace element that plays a critical role in growth and replication [22].However, it is a cofactor for several metalloenzymes as cytochrome c oxidase (COX), which is involved in mitochondrial metabolism, and Cu/Znsuperoxide dismutase (SOD1), which play an important role in cellular radical detoxification against ROS [23].Many researches detected the elevated demand for copper in tumor cells relative to most other tissues, from that decreasing Cu level was recommended for cancer treatment and protection [24].Although Cu is cytotoxic, its level is controlled by metallothioneins and glutathione to avoid copper cytotoxicity [25].Cu compounds are of antitumor activity based on the interactive properties of both copper and the ligand.Copper induces its cytotoxicity through its redox capacities.Cu (I) and Cu (II) redox states' interconversion in oxidation-reduction cycles.In addition, Cu renders enzyme activity through displacing other ions from the enzyme binding sites.As well, Cu might impair enzyme performance by oxidizing cysteines within iron-sulfur cluster proteins or reacting with hydrogen peroxide to generate ROS in a Fenton-type reaction to produce O2•-or •OH [26].Cu is of high DNA binding affinity results in promoting DNA breaks [27].Cu complexes may work as DNA topoisomerase inhibitors of antiproliferative anticancer activity, known as DNA-damaging drugs or poisons that arrest cancer cells in G2/M [28].Nanomaterials containing copper elements showed marked advantages in many different biomedical, chemical, and physical approaches, so they have been widely used in different fields [29].Interestingly, copper nanoparticles, which were synthesized using green synthesis methods, have shown various remarkable biological properties and can also be used in different medical approaches [30].Furthermore, copper nanoparticles can be used as DNA-cleavage agents and potent anticancer therapeutics because of their binding capacity and modifiable surface properties through conjugation with various biomolecules such as proteins and enzymes.Copper nanoparticles can also be used as effective drug delivery nano-formulations and molecular doping systems that act as cancer cell growth controllers [31].Cu nanoparticles introduced to experimental rats result in oxidative stress and cell death, as detected in increased MDA, superoxide dismutase activity, upregulation of caspases 3, 8, and 9, BCL2-associated X, Bax, and apoptotic peptidase activating factor 1 [32].
In other words, CuNPs may constitute a promising alternative agent for cancer therapeutics in the near future.However, more studies are needed to elucidate the full cellular mechanisms of CuNPs action for the treatment of cancer with higher effectiveness and lower cost.
Natural products are a valuable source of anticancer agents, representing an important alternative remedy for cancer in the twenty-first century.Plant phenolic compounds work as the primary precursors for nanoparticle production and stability through their activity as reducing and stabilizing agents [33].Chrysin (5,7-dihydroxyflavone) is of flavonoids, naturally present in diverse sources such as honey, propolis, mushrooms, passion fruit, and other plant species [34].Nonetheless, chrysin shows diverse biological and pharmacological effects, such as anticancer, antioxidant, anti-inflammatory, and antiviral activities.Over and above, chrysin exerts its anticarcinogenic effects through a pleiotropic molecular mechanism(s) of action on cell cycle, inhibits cell proliferation, angiogenesis, and metastasis as well as induces apoptotic processes [35].Consequently, chrysin could be considered an attractive candidate and/or a starting point for the development of novel anticancer agents.
Shedding the light on the mode of antineoplastic action of CuNPs, the present study aimed to evaluate the activity of copper nanoparticles (CuNPs) synthesized using chrysin as antitumor agent in vitro and as anticancer and radiosensitizer with low dose of gamma radiation in vivo against Ehrlich solid tumor.

Chemicals
Copper sulfate (CuSO 4 ) was supplied by Sigma Chemical Co., St. Louis, USA.Chrysin (5,7-dihydroxyflavone) was obtained from Alfa Aesar Thermo Fisher Scientific Co., Germany.All other chemicals used in the study were of analytical reagent grade.

Experimental Animals
The current study was performed using eighty Swiss albino female mice weighing 20 ± 5 g, supplied by the Nile Company for Pharmaceuticals and Chemical Industries, animal house breeding unit, Cairo, Egypt.Animals were preserved on a commercial standard pellet diet (21% protein) from Elqaed Company for animal feed and supplied with tap water ad libitum.Maintenance and treatments of animals was authorized by the ethics committee of the National Centre for Radiation Research and Technology.

Cell Lines
The human breast cancer cell MCF-7 cell line for in vitro study and Ehrlich ascites carcinoma (EAC) cell line for in vivo study were supplied by the Egyptian National Cancer Institute, Cairo University.Ehrlich ascites carcinoma was sustained weekly in Swiss albino female mice via intraperitoneal injection of 0.2 ml containing 2.5 × 10 6 viable EAC cells diluted by physiological sterile saline solution.

Tumor Transplantation
Developing a solid tumor was accomplished by injecting Ehrlich ascites carcinoma cells in the right thigh of the mice.The Bright-Line™ Hemocytometer was used for counting Ehrlich ascites carcinoma cells before inoculation.The solid tumor was developed in the right thigh region of the lower limb of each female mouse through intramuscular inoculation of 0.2 ml of EAC cells, containing 2.5 × 10 6 viable EAC cells.

Radiation Exposure
Mice whole-body irradiation with gamma radiation was carried out by using 137 Cesium biological irradiator source, gamma-cell-40 (Atomic Energy of Canada Limited, Chalk River, ON, Canada), at the National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority, Cairo, Egypt.Mice whole-body were irradiated with a single low dose of (0.5 Gy) gamma radiation at 0.653 rad/sec after tumor inoculation.

Preparation and Characterization of CuNPs
For CuNPs green synthesis, 10 ml of freshly prepared aqueous solution of copper sulfate (1 mM) were reduced by the dropwise addition of chrysin (0.1 mM).The mixture was constantly stirred at 50-60 °C, and an alkaline pH was maintained throughout the experiment.Excess chrysin and CuSO 3 were removed by dialysis for 24 h.The solution was filtered through a 0.2 μm Millipore filter [36].
Characterization of the prepared CuNPs' size, shape, and constituents is important for evaluating the biological performance of the newly synthesized nanoparticles.The morphology and size of CuNPs were determined by transmission electron microscopy (TEM), JEOL, model JEM2100, Japan.CuNPs size and size distribution were analyzed by dynamic light scattering (DLS), Malvern Zeta sizer, and Nano ZS ZEN 3600.The chemical structure of CuNPs sample was analyzed by Fourier transform infrared (FTIR) spectroscopy in the range of 400-4000 cm, Equinox 55 IR spectrometer.X-ray diffraction (XRD) analysis was obtained to identify copper incorporation in the synthesized nanoparticle, with an 11 XRD-6000 series, Shimadzu, Japan, using nickel-filter and Cu-Kα target of power 30KW, current 30 mA, voltage 40 kV, and λ 1.5064 Ǻ. CuNPs absorption spectrum was measured by scanning UV-Vis spectrophotometer at a range of 200-600 nm, using ultraviolet-visible spectrophotometer, Jenway UV-Vis spectrophotometer model 6505.

CuNPs Cytotoxicity on MCF-7 Cell Line
CuNPs and nano-chrysin's cytotoxic effects on MCF-7 cells were quantified as 50% cell growth inhibition (IC50) values by MTT assay.MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay is a colorimetric assay for assessing metabolic activity of MCF-7 cell line as indicator for cellular proliferation, viability, and cytotoxicity in response to CuNPs or nano-chrysin.A 96-well cell culture plate was inoculated with 1 × 10 5 MCF-7 cells/ml (100 µl/ well) and incubated at 37 °C for 24 h to develop a complete monolayer sheet.Media was discarded from the plate then, 50 µl of different concentrations of CuNPs or nano-chrysin (0.5, 1.0, 2.0, 3.9, 7.8, 15.6, 31.25,62.5, 125, 250, 500, and 1000 µg/ml) and 50 µl of MTT solution were added into each well and incubated for 3 h at 37 °C.MTT solvent (dimethyl sulfoxide) 150 µl was added into each well to dissolve insoluble blue formazan crystals formed by NAD(p)H-dependent oxidoreductase enzyme in viable cells.Colorimetric changes compared to the control without any stimuli were analyzed spectrophotometrically at 590 nm by a microplate reader, Sunrise, TECAN, Inc, USA.A blank cell-free control and an untreated cell control were included in each experiment's triplicate for each concentration [37].

CuNPs Toxicity in Mice (LD50)
An initial necessary step in the assessment of the toxic characteristics of any new compound as CuNPs in vivo is the determination of median lethal dose (LD 50 ) value (the dose that kills 50% of the tested animals), which supplies information about the health hazards likely to emerge from short-term drug exposure.Forty Swiss albino female mice were allocated equally in four groups and injected intraperitoneally with increasing doses of CuNPs (0.1, 5, 10, 30, 70, 90, and 100 mg/kg body weight).Mortality was recorded after 24 h.The LD 50 value was calculated according to [38].The appropriate dose of CuNPs to be used in vivo was calculated as 1/10 of the LD 50 value (LD 50 = 6.67 mg/kg body weight).

Experimental Design
After 7 days of acclimatization, eighty female mice (20 ± 5 g) were randomly divided into 8 groups (n = 10 per group): 1. Control (C) group: Mice were injected intraperitoneally with 0.2 ml of sterile saline.2. CuNPs group: Mice were injected intraperitoneally with 0.2 ml (0.667 mg/kg b.w.) of CuNPs started from the seventh day of the experiment daily for 2 weeks (5 times each week).3. Radiation (R) group: Mice's whole body was irradiated with a single dose of (0.5 Gy) gamma radiation on the eighth day of the experiment.4. CuNPs/R group: Mice were injected intraperitoneally with 0.2 ml (0.667 mg/kg b.w.) of CuNPs as group 2, and irradiated with a single dose of (0.5 Gy) gamma radiation as group 3. 5. Ehrlich solid carcinoma (EC) group: Mice were inoculated intramuscularly with 0.2 ml of EAC cells (contains 2.5 × 10 6 viable EAC cells) in the right thigh of the lower limb on the first day.6. EC/CuNPs group: Mice developed Ehrlich solid tumor and were intraperitoneally with 0.2 ml (0.667 mg/kg b.w.) of CuNPs as group 2. 7. EC/R group: Mice developed Ehrlich solid tumor were irradiated with a single dose of (0.5 Gy) gamma radiation as group 3. 8. EC/CuNPs/R group: EC-bearing mice intraperitoneally with 0.2 ml (0.667 mg/kg b.w.) of CuNPs as group 2, and irradiated with a single dose of (0.5 Gy) gamma radiation as group 3.
At the end of the experiment, animals were sacrificed under diethyl ether anesthesia.Blood samples were collected and solid tumors were excised for biochemical and histopathological investigations (Fig. 1).

Tumor Volume Monitoring
Solid tumor volume was monitored by using Vernier caliper.Tumor volume was measured at the 10th, 15th, and 20th days of EAC cell inoculation and calculated using the equation: tumor volume = 1/2 (length × width 2 ), where length represents the greatest longitudinal diameter, while the width represents the greatest transverse diameter [39].

Kidney and Liver
Serum creatinine was evaluated colorimetrically at 500-550 nm by measuring a colored complex formed of creatinine with picrat in an alkaline medium using a commercial assay kit of Biodiagnostic Company, Egypt.
Alanine aminotransferase (ALT) activity in the serum was measured colorimetrically using the method of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).The reaction principle is to convert the pyruvate results from alanine transaminase reaction into lactate by adding lactate dehydrogenase and β-nicotinamide adenine dinucleotide, reduced form (NADH) to the reaction medium.The reaction was monitored at a UV absorbance of 339 nm.A commercial assay kit of QCA, Amposta, Spain, was used.

Determination of Malondialdehyde (MDA)
Lipid peroxides in terms of malondialdehyde (MDA) were measured in brain tissues according to the method of Yoshioka et al. [40].The assay depends on the colorimetric reaction of MDA with thiobarbituric acid, giving a pink complex called thiobarbituric acid-reactive substance (TBARS) that can be measured at 532 nm.MDA contents were expressed as nmol/g wet tissue.

Reduced Glutathione (GSH) Level
GSH level was measured according to Ellman [41].Protein content of the sample was precipitated by trichloroacetic acid (TCA), and the glutathione in the tumor homogenates was reacted with DTNB (5-5′-dithionitrobenzoic acid; Sigma) to give a yellow chromophore of TNB (thionitrobenzoic acid), spectrophotometrically measured at 412 nm.GSH (Sigma) was used as a standard.GSH concentration was expressed as mg/g wet tissue.

Catalase (CAT) Activity
CAT activity was assayed in tumor the tissue extracts using colorimetric assay kit of Biotech Inc., Egypt.In brief, samples were diluted in the provided assay buffer and added to the wells of a half-area clear plate.Hydrogen peroxide was added to each well, and the plate was incubated at room temperature for 30 min.The supplied colorimetric detection reagent was added, followed by diluted horseradish peroxidase (HRP), and incubated at room temperature for 15 min.The HRP reacts with the substrate in the presence of hydrogen peroxide to convert the colorless substrate into a pinkcolored product.The colored product was read at 560 nm.

Caspase-3 Level
Caspase-3 level was calorimetrically assayed in the tumor tissue homogenate of each group via ELISA based on sandwich enzyme immunoassay technique using Rat Caspase 3, ELISA kit of Cusabio Co., USA, code no.CSB-E08857r.

Gene Expression of Nuclear Factor Kappa B (NF-κB), p38 Mitogen-Activated Protein Kinase (p38 MAPK), and Cyclin D 1
To evaluate the variations of messenger RNA (mRNA) expression of NF-κB, p38 MAPK, and cyclin D 1 qrt-PCR was performed.

RNA Extraction
Total RNA was extracted by using the Qiagen tissue extraction kit, Qiagen, Cat.No./ID:69,504.The concentration of isolated RNA was determined spectrophotometrically by measuring the absorbance at 260 and 280 nm, giving 260/280 ratio > 2.0, using dual-wavelength Beckman, Spectrophotometer, USA.All samples were stored at − 80 °C until the analysis of complementary DNA synthesis reaction.
Complementary DNA (cDNA) Converting total RNA to cDNA was accomplished using the sense and antisense primers, Table 1.Polymerase chain reaction was performed using a high capacity cDNA reverse transcription kit of Thermo Scientific™, Cat.No. FERK1621.Synthesis of cDNA was carried out by adding 3 μl of primers to 10 μl of (1-2 µg) of total RNA and denatured for 5 min at 65 °C in the thermal cycler, then cooled to 4 °C.Then, the reaction mixture was added composed of: 5 μl of first-strand buffer, 2 μl of 10 mM deoxyribonucleotide triphosphates (dNTPs), 1 μl of 40 U/μl RNase inhibitor, 1 μl of 50 U/μl MMLVreverse transcriptase enzyme, and 10 μl of DEPC-treated water.The mixture was incubated at 37 ºC for 1 h, then at 95 ºC for 10 min, and finally cooled at 4 °C.

Qrt-PCR Reaction
Was carried out in duplicate in a reaction volume of 25 μl, containing: 2 × SYBR Green PCR Master Mix of Applied Biosystems, Waltham, MA, USA and (2-3 μl) of cDNA; also 900 nM of each primer was added.The thermal cycles conditions applied for each gene were: for NF-κB included preliminary denaturation at 95 °C for 10 min, followed by 36 cycles of denaturation at 98 °C for 30 s, annealing at 60 °C for 60 s, and elongation at 72 °C for 15 s, followed by a final elongation step at 72 °C for 5 min.The thermal conditions for p38MAPK involved 1 denaturation cycle at 95 °C for 2 min, 30 cycles at 95 °C for 1 min, 55 °C for 1 min, and 72 °C for 1 min, and 1 cycle at 72 °C for 5 min.While for cyclin D1 involved initial denaturation at 95 °C for 1 min, followed by 40 cycles of denaturation at 95 °C for 12 s, and annealing at 60 °C for 1 min.Qrt-PCR data analysis was performed by using the Applied Biosystem with software version 3.1, StepOne™, USA.The comparative C T method was used to calculate the relative expression of the target mRNA.To normalize all values, the GAPDH gene was used as the control gene [42].

Histopathological Examination
Ehrlich tumor-bearing thigh tissue samples preserved in 10% formalin were dehydrated by ethanol and embedded in paraffin wax.For histopathological examination, 5-μm-thick sections were cut and then stained using hematoxylin and eosin [43] before their examination under a light microscope.

Statistical Analysis
All data were stated as mean ± standard deviation (SD).Oneway analysis of variance (ANOVA) was used to analyze the data, followed by the least significant difference (LSD) as a post hoc test.The significance level between mean values   UV-Vis absorbance of CuNPs showed a characteristic surface plasmon absorption band at 273 nm, which indicated the formation of CuNPs, Fig. 2C.DLS analysis revealed CuNPs particle size range from 18.92 to 412.5 nm, with the highest distribution of size 25.37 nm representing 24.3%, followed by the size of 29.39 nm representing 20.8% of the total nanoparticle amount.The polydispersity index (PDI) explains the average uniformity of the particle solution, which was 0.448, indicating acceptable particle size distribution.

Characterization of CuNPs
Furthermore, the confirmation of CuNPs was made by XRD analysis.The intense and sharp peaks of XRD showed that CuNPs was crystalline in nature, Fig. 2E

CuNPs and Nano-Chrysin Cytotoxicity on MCF-7 Cell Line
The anticancer and anti-proliferative activity of CuNPs was detected in vitro in human breast cancer MCF-7 cell line using MTT assay, Fig. 3.The antitumor activity was expressed as the reduction of cell viability in response to cell exposure to different concentrations of the nanomaterial compared to the untreated control cells.The results exhibited a significant reduction in the proliferation activity of MCF-7 cells treated with CuNPs, recorded IC 50 value of 57.2 ± 3.1 μg/ml, while nano-chrysin IC 50 was 125.4 ± 6.2 μg/ml (IC 50 is the concentration that reduced the initial count of viable MCF-7 cell line by 50% compared to untreated control cells).

Biochemical Analysis
To assess different treatments for toxicity in the liver and kidney, ALT and creatinine were evaluated.Results revealed significant (p ≤ 0.05) elevation in ALT activity in the serum of EC group of mice who developed solid tumors by 276.7% when compared to the normal control group.A significant (p ≤ 0.05) reduction in ALT activity was detected in tumorbearing mice treated with CuNPs or exposed to wholebody gamma irradiation or combined treatment of them by − 49.0, − 8.9, and − 53.3%, respectively, compared to EC group, Fig. 5A.
In addition, data analysis of creatinine results revealed a significant (p ≤ 0.05) increase in creatinine level in EC group by 172.2% when compared to the normal control group.Whereas, treatment with CuNPs (EC/CuNPs group) showed nonsignificant results with a percent of change of 2.0%, while irradiation exposure (EC/R group) showed an increase in creatinine level with a percent of change of 20.0%.On the other hand, results of creatinine level of EC/ CuNPs/R group revealed significant (p ≤ 0.05) decrease with percent of change of − 18.4% in comparison to untreated EC group, Fig. 5B.
Calcium concentration was detected in the tumor tissue extracts by atomic absorption, Fig. 6A.Our results revealed a significant (p ≤ 0.05) elevation in Ca + 2 level in tumor tissue by 176.7% compared to healthy normal tissue.This elevation was significantly (p ≤ 0.05) reduced with treatments of CuNPs, irradiation, and the combined treatment (EC/CuNPs, EC/R, and EC/CuNPs/R groups) by − 41.2, − 56.4,− 31.2%,respectively, compared to untreated EC group.
CuNPs and radiation exposure caused changes in oxidative stress status of tumor tissue which was detected by determination of MDA level as a product of lipid peroxidation, Tumor cell antioxidant levels are associated with tumor progression and increased resistance to chemotherapeutic drugs.Antioxidant state was estimated by GSH level and CAT activity determination, Fig. 6 C, D. The current data revealed a statistically significant (p ≤ 0.05) decrease in GSH and CAT levels in the tumor extract by − 54.9 and − 52.6%, respectively, when compared to the normal tissue.Different treatments of CuNPs and irradiation (EC/CuNPs, EC/R, and EC/CuNPs/R groups) significantly (p ≤ 0.05) reduced GSH by − 22.2, − 15.8, and − 35.5%, respectively, while decreased CAT activity by − 11.1, − 5.7, and − 18.5%, respectively, when compared with that of untreated EC group.
The suppression in caspase-3 level in cancer cells pointed to the induction of tumorigenesis.The present data revealed a significant (p ≤ 0.05) decrease in caspase-3 level by − 78.9% in the tumor tissue when compared to the control, Fig. 6E.In response to different treatments of CuNPs and irradiation, the level of caspase-3 was significantly (p ≤ 0.05) elevated (EC/CuNPs, EC/R, and EC/CuNPs/R groups) by 529.8, 614.0, and 824.6%, respectively, when compared to untreated EC group.Comparing data of treatment groups indicated that combined treatment of greater effect on stimulation apoptosis compared to other treatments.
Qrt-PCR analysis was performed for detecting the effect of CuNPs and gamma radiation on the gene expression of NF-κB, p38 MAPK, and cyclin D1 in the tumor tissue, Fig. 7 A, B, C, respectively.Results illustrated that gene Fig. 4 Inhibitory effect CuNPs and low dose γ-radiation exposure on Ehrlich solid tumor size of experimental groups.EC, Ehrlich solid tumor group; EC/CuNPs, Ehrlich solid tumor mice treated with CuNPs group; EC/R, Ehrlich solid tumor mice exposed to 0.5 Gy of wholebody gamma irradiation group; EC/CuNPs/R, Ehrlich solid tumor mice treated with CuNPs and exposed to 0.5 Gy of whole body gamma irradiation group.Data presented as mean ± SD.Data were considered significant at p ≤ 0.05.a significant compared to the control; b significant compared to EC group at the same time expression of NF-κB was significantly upregulated by 400 folds compared to the control.On the other hand, comparing different treatments (EC/CuNPs, EC/R, and EC/CuNPs/R groups) to untreated EC group showed a significant reduction in the expression of NF-κB by − 0.4, − 0.2, and − 0.7 folds, respectively, Fig. 7A.
Analyzing Qrt-PCR data pointed to a significant upregulation of p38 MAPK gene expression by 0.7 folds in the tumor tissue of EC group compared to the control.Different treatment groups (EC/CuNPs, EC/R, and EC/CuNPs/R groups) result in a significant downregulation of p38 MAPK gene expression by − 0.6, − 0.5, and − 0.82 folds, respectively, compared to untreated tumor group EC group.
Regarding cyclin D1 gene expression, it showed significant upregulation in the tumor tissue by 1.8 folds compared to the normal control group.A significant downregulation of cyclin D1 was detected in the tumor tissues of different treatment groups (EC/CuNPs, EC/R, and EC/CuNPs/R groups) by − 0.3, − 0.06, and − 0.6 folds, respectively, when compared with untreated tumor group.
Examining the effect of the combination treatment with the single treatment is important.This combination may provide an effect equal (additive), greater (synergistic), or less (antagonistic) than the sum of the individual component effects.The observed value (OV) of the combined extracts and the expected value (EV), which is the mathematical sum of the TAC half values of the individual extracts under test, were compared.If the OV were significantly higher than the EV obtained from the same pair of individual extracts (p < 0.05), the combined extract exhibited synergistic interaction.While, if the OV was significantly lower than the EV, the interaction was antagonistic (Habashy et al. 2018) [44].
In view of the results, combined treatment of EC/ CuNPs/R was found to be of synergistic effect on MDA and calcium.While it was of additive effect on ALT, creatinine, GSH and CAT, while it was of antagonist effect on tumor volume, Casp-3, Nf-kB, p38MAPK, and cyclin Table 2.

Histopathological Examination
Ehrlich solid tumor tissue histopathological examination under the light microscope confirmed the observed inhibition of tumor growth for treated groups in addition to the high growth rate of the control group.The outcomes of EC group revealed compact aggregation of the tumor cells, which spread within the muscular and subcutaneous tissues, arranged in the form of clusters or sheets with deeply basophilic pleomorphic nuclei with nuclear vesicularity.Ehrlich solid tumor showed groups of large, round, and polygonal cells with pleomorphic shapes, hyperchromatic nuclei, binucleation, and anisocytosis.A moderate number of newly formed blood capillaries (neovascularization) were seen in the surrounding tissue.The tumor mass is surrounded by a massive area of necrosis without inflammatory reaction [2],

Discussion
Combined chemoradiotherapy has been demonstrated to enhance the efficiency of both chemotherapy and radiotherapy, thus improving cancer treatment.Beyond this, our hope is pinned on tailoring an optimized preclinical therapeutic program based on the biology of the disease and further the evolutionary principles of tumor development.In this connection, such trial was projected to formulate a novel Cu-based nanocomplex under a direct molecular reduction mechanism using the nontoxic and eco-friendly phytochemical chrysin as a strong reducing and stabilizing agent.This biomimetic process completely complied with the principles of green chemistry as it used water as a benign solvent over the course of the preparation and storage of chrysin CuNPs.
Former studies have revealed that copper complexes have the potential to be created as targeted therapies for cancer due to the higher copper uptake by cancer cells compared to normal cells, also its potential function as radiosensitizer, which enhances tumors response to radiation even at relatively low concentrations in the presence and absence of oxygen [6,45,46].
Copper nanoparticles in this study were produced via eco-friendly method using chrysin.To establish their fine nanostructure, the biosynthesized CuNPs were characterized via a panel of physicochemical analyses such as TEM, FTIR, UV/VIS spectrophotometer, DLS, and XRD techniques.Analyzing TEM and DLS data size revealed that CuNPs size range results of TEM were 21.19 to 70.79 nm, while DLS analysis detected particles size range from 18.92 to 412.5 nm with size distribution more than 90% for nanoparticles of sizes < 100 nm with homogenous distribution indicated with PDI of 0.448.TEM measures the physical size of the electron dense core, whereas DLS reports the hydrodynamic size of the particle which includes a diffuse layer around the particle indicating bigger sizes.
Nanoparticle size and shape are very important criteria for therapeutic activities.In the present work, CuNPs have elaborated a therapeutic activity regarding the size, as tumor cells were able to accumulate circulating nanoparticles smaller than 150 nm compared to normal cells [47].Smaller nanoparticles (1-100 nm) can interact with plasma membranes and penetrate and pass through the cell membrane via phagocytosis, endocytosis, or micropinocytosis [48].Nanoparticle shape plays an important role in cell bioactivity and response, as different shapes induce various cellular responses [49].Our TEM and XRD results exhibited that CuNPs were of a crystalline form and irregular shape.In other words, nanoparticles are of sharp shape, high surface roughness, and crystalline phase that increase their cytotoxicity when coming into contact with the cell membrane and subsequently induce cell death [50].CuNPs were characterized with absorption spectral peak at 273 nm, which represents surface plasmon resonance of copper metal nanoparticles [51].Additionally, the FTIR spectra were examined to determine the surface adsorption of functional groups on nanoparticles [52], and they can also be used to identify possible biomolecules responsible for the capping and stabilization of synthesized metal NPs.The shifting in the hydroxyl (OH) group, (C = C) band corresponding to the single (C-H) or (C-N) bond, C = O of CuNPs spectra when compared to that of chrysin indicates the coordination occurs between Cu and chrysin.
The biological activity of CuNPs against cancer cells was detected in the human breast cancer MCF-7 cell line.Regarding the in vitro toxicity of CuNPs against MCF-7 cells, the result revealed a significant reduction of cell viability relative to control in a dose-response manner.CuNPs biologically synthesized using brown seaweed Sargassum polycystum and copper sulfate exhibited antitumor activity against MCF-7 cells with IC 50 value equal to 61.25 μg/ml [53].Copper compounds were found to induce MCF-7 cell death through autophagy [54], cell cycle arrest, and inhibition of topoisomerase I [55].Chrysin as well has been found of anticancer activity on MCF-7 cells in a dose and timedependent manner detected by MTT assay, which revealed IC 50 equal 19.5 µM after incubation for 48 h and 9 µM after incubation for 72 [41].Chrysin has been found to induce its antitumor activity through upregulating apoptotic pathways [56], inhibit angiogenesis [57], metastasis formation [58], and suppress DNA topoisomerases [59], as well as histone deacetylase.
Ehrlich ascites carcinoma (EAC) is a well-established aggressive murine model specific for mice.Ehrlich solid tumor is a rapidly growing carcinoma developed by inoculation of EAC cells intramuscularly, in which cells increase their nuclear materials continuously at the expense of their normal apoptotic rate [61].
In the current study, mice inoculated with EAC cells showed a significant increase in gained tumor size with respect to the control.Many authors attributed the increase in tumor volume to the massive drop in apoptosis, which contrasted with dramatic changes in cell cycle with increased proliferation rate [62].CuNPs and gamma irradiation administered to EAC mice significantly reduced tumor volume compared to untreated EC mice group.CuNPs and/ or gamma irradiation may induce their antitumor effect through cell division delaying impact and apoptosis stimulation.Histological findings clearly demonstrated regression of neoplastic mass as well as extensive number of necrotic and apoptotic cells.Also, chrysin has been found to reduce EAC tumor size through inhibiting VEGF and inflammatory molecules involved in angiogenesis [63], suppressing DNA topoisomerases [64], and histone deacetylase [65], as well as downregulating tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β) [66].
CuNPs were found to stimulate oxidative stress in tumor tissue homogenates as detected by MDA elevation and reduce antioxidant state as represented by a reduction in GSH and CAT activity compared to untreated tumor tissue, which eventually results in tumor cell death as detected in histopathological analysis that showed degenerative changes in the form of vacuolation of neoplastic cells in the tumor tissue of CuNPs/EC treated mice.It was reported that CuNPs have the ability to increase cell membrane flexibility, enter inside the cell, and interact with different biomolecules, causing DNA degradation and chromatin condensation.CuNPs can also affect the cell cycle by enhancing (G2/M phase) cell cycle arrest [67].The release of Cu into tumor cells enhances reactive oxygen species (ROS) as well as nitric oxide (NO) production, which results in DNA fragmentation, induces pro-apoptotic protein upregulation such as Bax, and enhances caspase-3, caspase-8, and caspase-9 generation that motivates cancer cells apoptosis [68] even in solid tumor hypoxic condition [69].Additionally, chrysin had the ability to reduce STAT3 phosphorylation, which inhibits tumor progression and disrupts hypoxia-induced VEGF gene expression.The combination between chrysin with anticancer drugs improved the cytotoxic effects against various cancerous cells without damaging healthy neighboring normal cells [70].Whole body Irradiation (0.05 GY) was found to increase the levels of DC-related cytokines (IL-2, IL-12, and IFN-γ), promoting biomolecules structural modification [71], triggering anti-tumor immunological responses such as scavenging reactive chemical intermediates, promoting DNA damage repair, reducing inflammation, inducing selective cell apoptosis or senescence, and upregulating both the innate and adaptive arms of the anticancer immune system, allowing the transfer of naive helper T cells to Th1 cells [72][73][74][75].Low dose of gamma radiation has the ability to reduce the occurrence, growth, and spread of cancers [76][77][78] as well as increase the effectiveness of radiation.
Ehrlich tumor had the ability to increase AFP, ALT, AST, Bcl2, CEA, cholesterol, creatinine, urea, MDA, PCNA, potassium, triglycerides, TNF-α, and NF-kB levels while reducing catalase, GSH, P53, and SOD [2].It was found that tumor induction damages many internal organs, including the liver and kidney.Worth to mention that cancer promotes liver and kidney damage through extensive regions of necrosis and congestion, as well as mononuclear cell infiltration in the liver and kidney [79].The results of ALT and creatinine are in harmony with previous research that detected the ameliorative effect of copper complex nanoparticles on ALT activity and creatinine levels in hepatocellular carcinoma [80].Additionally, chrysin has the ability to reduce elevated ALT and creatinine levels in rats with chronic kidney disease [81].Moreover, total body exposure to a low dose of γ-radiation has the ability to modulate the elevated serum ALT and creatinine levels induced by Ehrlich solid tumor inoculation [82].
In addition, results exhibited a significant increase in calcium level in the tumor tissue compared to normal tissue, which was significantly decreased with CuNPs and/or γ-radiation exposure compared to untreated tumor tissue.The disruption of Ca 2+ homeostasis resulting from alteration of Ca 2+ channels/transporters/pump activities plays a major role in tumor initiation, development, angiogenesis, and metastasis [83].Calcium ions are essential for cancer cell proliferation and death, serving as major signaling agents and ultimately determining the fate of the cell.When a normal cell transforms into a cancer cell, there is a significant rearrangement of Ca 2+ pumps, Na/Ca exchangers, and Ca 2+ channels.This change promotes increased proliferation while impairing a cell's ability to die [84].Copper revealed its cytotoxic activity by enhancing endoplasmic reticulum stress and disrupting calcium ions Ca 2+ homeostasis [85].Additionally, chrysin exhibited anti-tumor activity against choriocarcinoma cells through modification of mitochondrial membrane potential, disruption of Ca 2+ levels in cytosol, enhancing generation of reactive oxygen species (ROS), and inducing lipid peroxidation, which affects intracellular Ca 2+ homeostasis resulting in cancer cell damage [86].Radiation therapy employs a cell death mechanism triggered by DNA damage, which activates pro-apoptotic Bcl-2 family proteins and evokes enormous Ca 2+ release from the endoplasmic reticulum, resulting in cell death [87].Moreover, low doses of ionizing radiation (0.1-0.5 Gy) were found to suppress intracellular (Ca 2+ ) influx in the activated rat basophilic leukemia [88].
MDA, a biomarker for oxidative stress, was elevated in tumor tissue compared to normal controls, as it is the end product of lipid peroxidation and its level is related to tumor progression.[89].At the same time, Ehrlich carcinoma showed depression in the antioxidant state through GSH content and CAT activity inhibition compared to the normal control.CuNPs and/or low-dose gamma radiation treatment increased oxidative stress state as presented by the elevation in MDA levels and decreased antioxidant state as presented by the depression of GSH content and CAT activity compared to the untreated tumor group.Copper, copper complexes, and CuNPs have been found to stimulate oxidative stress and induce ROS generation, resulting in MDA elevation.At the same time, they reduce antioxidant activity by decreasing GSH content and CAT activity [90,91], enhancing DNA destruction, and stimulating different signals, resulting in apoptosis and cell death [92,93].Furthermore, low doses of ionizing radiation induce antioxidant protective mechanisms through modulation of various antioxidant levels such as GSH and SOD, increasing anti-cancer activity, enhancing p53-related apoptosis of destroyed cells and precancerous cells apoptosis through reactive oxygen species (ROS)/reactive nitrogen species (RNS) and cytokine signaling, as well as inhibiting inflammation disease [94].Additionally, combined treatment of nanocomposite with low dose exposure of gamma radiation was reported to induce cancer cell damage by increasing MDA while decreasing GSH, CAT, and SOD in Ehrlich tumor tissue [95].
Induction of oxidative stress plays an important role in stimulating apoptosis in cancer cells.Ehrlich tumor expressed lower level of caspase-3 compared to normal control, CuNPs, and/or low dose γ-radiation significantly elevated caspase-3 compared to that of untreated tumor tissue.Copper and CuNPs have the ability to stimulate apoptosis by caspase-dependent and independent pathways through induction of pro-apoptotic protein (Bax) and suppression of anti-apoptotic protein (Bcl-2) [66,90,96], while chrysin activates apoptosis through intrinsic pathways of apoptosis in view of p53 and Bak, caspase-9 and caspase-3 enhancement, and Bcl2 downregulation [96].On the other hand, gamma rays may provoke apoptosis through ROS [97].
Ehrlich tumor tissue significantly stimulated oncogenes expression of NF-κB, p38 MAPK, and cyclin D1 compared with normal control.CuNPs and/or gamma radiation modulated gene expression involved in the promotion and growth of cancer cells.Generally, p38 MAPK promotes the downstream induction of transcription factors such as NF-κB, which is essential for cancer cell survival, invasion, and migration, whereas its inhibition promotes activating caspases-3, 9, and 8 in colon cancer cells [98].
Copper has been evaluated as an activator and essential cofactor for MAPK/ERK kinase (MEK), as well as a key molecule in the BRAF/MEK/ERK pathway [99].Copper antiproliferation activity works by inhibiting the non-canonical and canonical NF-κB pathway through ROS production, preventing IKK kinase complex phosphorylation of the inhibitory units (IκBα) associated with NF-κB [100].On the other hand, copper nanoparticles coated with phenols or flavonoids such as curcumin alleviated copper toxicity and exhibited antiangiogenic and anti-inflammatory activity through suppressing TNF-α, IGF1, VEGF, IL-6, FGFb, TGFβ, and EGF [101].While, chrysin showed antiproliferative activity by suppressing p38 MAPK expression, which involved JNK and NF-κB in cardiac cells [102].Exposure to low dose of ionizing radiation was found to suppress cancer cell proliferation via suppressing p38 kinase in MCF-7 human breast cancer cells [103], inhibiting JNK as well as ERK phosphorylation [87], and down-regulating NF-κB through suppressing TNFα-induced degradation of inhibitor of kappa B (IκB) protein and release of p65 subunit to the nucleus, reducing NF-κB activity [104].
Cyclin D1 analysis in untreated tumor tissue exhibited provoked expression of Cyclin D1 in contrast to normal control; however, this elevation in gene expression was reduced as a result of CuNPs and/or gamma radiation treatments.Cyclin D1 is a marker of cell proliferation as it regulates the cell cycle transition from the G1 phase to the S phase.Our results go along with a former study [105], which stated that CuNPs induce apoptosis, antiproliferative effect, and cell cycle arrest at the G2/M of human extravillous trophoblast cells.In the same line, copper complexes inhibited proliferation and caused cell cycle arrest at G1 phase via down-regulation of cyclin D1 as well as cyclin E1 and upregulation of cyclin-dependent kinase inhibitors such as (CKIs) p27 protein [106].Furthermore, chrysin is of antiproliferative activity causes cell cycle arrest on G1 phase and G1/S in skin cancer cell lines in EGF-stimulated JB6 P + cells [107].Low doses of radiation have been shown to affect normal cellular response, especially proliferation.Low dose of ionizing radiation was found to stimulate cyclin D1 and may induce adaptive resistance [108].This effect was markedly attenuated by combined treatment with CuNPs.In other words, the combined treatment revealed a stronger inhibitory effect on cyclin D1 expression, causing cell cycle arrest, than each treatment alone.
Histopathological examination of tumor tissue sections illustrated the stimulatory effect of combined treatment on necrosis and apoptosis found all over the tumor tissue.These results are attributed to the ability of CuNPs to promote antiangiogenic, apoptotic, and necrotic activities [109].

Conclusion
Copper nanoparticles and copper complexes could be potential chemotherapy against cancer cells due to their high uptake by cancer cells and their potential effect as radiosensitizers even at low doses, in the presence and absence of oxygen (hypoxia) [6,45,46].The use of nanoparticle-based drug delivery system is regarded as a viable strategy for increasing the bioavailability of chrysin and allowing the use of copper and low dose of gamma radiation in cancer therapy through using a newly synthesized CuNPs as a radiosensitizers combined with exposure to low dose of radiation.Based on the results obtained in the present study, the following mechanisms may be behind the anti-tumor effects of the combined treatment of CuNPs and low dose of gamma radiation, as they synergize in inducing oxidative stress state, which triggers signaling pathways of intrinsic apoptosis as well as antitumor and antiproliferative activities via Nf-kB/ p38 MAPK signaling, and cell cycle arrest via cyclin D1.Hopefully, our data provides therapeutic rationale for using CuNPs capped by chrysin as adjuvant therapy with low dose of gamma radiation to promote radiotherapy.

Fig. 1
Fig. 1 Experimental design and treatment protocol.EC, Ehrlich solid tumor; CuNPs, copper nanoparticles; R, gamma radiation Chrysin conjugation to Cu and formation of nanoparticles were analyzed.TEM analysis confirms the size and morphology of synthesized CuNPs.TEM micrographs exhibited an irregular round shape with different sizes ranging from 21.19 to 70.79 nm of CuNPs.FTIR study was performed to ensure the presence of chrysin as coating layer on NPs acting as a capping agent.The FTIR spectrum resented in Fig. 2B revealed strong and medium peaks as follows: a strong broad signal at 3455.79 cm −1 (represents hydroxyl group), medium signals at 2908.61 and 2836.67 cm −1 (representing C-H bond), a signal at 2083.36 cm −1 (represents C-H bending), a strong signal at 1634.64 cm −1 (represents C = O bond), a medium signal at 1395.46 cm −1 (represents O-H bond), a strong signal at 1113.94 cm −1 (represents C-O bond), and a strong signal at 667.21 cm −1 (represents C = C bond) indicating the interactions of Cu with chrysin which stabilizing the nanoparticles formed through the surfacebound forming coating layer.
Volume Monitoring Antitumor activity of CuNPs was detected in vivo through monitoring tumor size changes of Ehrlich solid tumor during the time of the experiment, Fig. 4. Ehrlich solid tumor was induced by inoculation of 2.5 × 10 6 of EAC cells in the right thigh region of the lower limb of female mice.Tumor size of the untreated tumor group (EC group) on the 10th day of inoculation recorded 518.05 ± 274.3 mm 3 , which significantly (p ≤ 0.05) increased and reached 1482.2 ± 422.7 mm 3 on the 20th day of inoculation compared to that of 10th day.A significant (p ≤ 0.05) reduction in the tumor size was detected on the 20th day of the inoculation in response to CuNPs and/or low dose gamma radiation exposure (EC/CuNPs, EC/R, and EC/CuNPs/R groups), with percentage of reduction of − 22.6, − 19.21, and − 63.88%, respectively, compared to untreated EC group.

Fig. 6B .
Fig. 6B.Results detected a significant (p ≤ 0.05) elevation in MDA levels in the tumor tissue by 35.1% compared to that of the control group.Treating tumor-bearing mice with CuNPs, irradiation, and combined treatment (EC/CuNPs, EC/R, and EC/CuNPs/R groups) significantly (p ≤ 0.05) elevated MDA levels by 131.7, 64.2, and 236.2%, respectively, compared to untreated EC group.Tumor cell antioxidant levels are associated with tumor progression and increased resistance to chemotherapeutic drugs.Antioxidant state was estimated by GSH level and CAT activity determination, Fig.6 C, D. The current data revealed a statistically significant (p ≤ 0.05) decrease in GSH and CAT levels in the tumor extract by − 54.9 and − 52.6%, respectively, when compared to the normal tissue.Different treatments of CuNPs and irradiation (EC/CuNPs, EC/R, and EC/CuNPs/R groups) significantly (p ≤ 0.05) reduced GSH by − 22.2, − 15.8, and − 35.5%, respectively, while decreased CAT activity by − 11.1, − 5.7, and − 18.5%, respectively, when compared with that of untreated EC group.The suppression in caspase-3 level in cancer cells pointed to the induction of tumorigenesis.The present data revealed a significant (p ≤ 0.05) decrease in caspase-3 level by − 78.9% in the tumor tissue when compared to the control, Fig.6E.In response to different treatments of CuNPs and irradiation, the level of caspase-3 was significantly (p ≤ 0.05) elevated (EC/CuNPs, EC/R, and EC/CuNPs/R groups) by 529.8, 614.0, and 824.6%, respectively, when compared to untreated EC group.Comparing data of treatment groups indicated that combined treatment of greater effect on stimulation apoptosis compared to other treatments.Qrt-PCR analysis was performed for detecting the effect of CuNPs and gamma radiation on the gene expression of NF-κB, p38 MAPK, and cyclin D1 in the tumor tissue, Fig.7A, B, C, respectively.Results illustrated that gene Fig. 8A.EC-bearing mice treated with CuNPs (EC/CuNPs group) showed degenerative changes in the form of vacuolation of neoplastic cells.Pyknosis and karyolysis of Ehrlich tumor cells appeared markedly in the central regions of the tumors.Numerous numbers of inflammatory cells, mainly lymphocytes, macrophages, and multinucleated tumor giant cells, invaded the necrotic areas, and few fibrous tissue proliferation, Fig. 8B.ECbearing mice treated with low-dose gamma radiation

Fig. 5
Fig. 5 Effect of CuNPs and low dose gamma radiation on A ALT activity and B creatinine level.Exposed to CuNPs: mice treated with CuNPs, R: mice exposed to whole body gamma irradiation, CuNPs/R: mice treated with CuNPs and exposed to whole body gamma irradiation, EC: Ehrlich solid tumor group, EC/CuNPs: Ehrlich solid tumor mice treated with CuNPs group, EC/R: Ehrlich solid tumor mice exposed to whole body gamma irradiation group, EC/ CuNPs/R: Ehrlich solid tumor mice treated with CuNPs and exposed to 0.5 Gy of whole body gamma irradiation group.Data were represented by mean ± SD (n = 6).Data were considered significant at p ≤ 0.05.Where a, significance compared to control; b, significance compared to EC; c, significance compared to EC/CuNPs; d, significance compared to EC/R; e, significance compared to EC/CuNPs/R

Fig. 6
Fig. 6 CuNPs and low-dose gamma irradiation exposure effect on mice bearing Ehrlich tumor.Parameters detected in the tumor tissue homogenate were A concentration, B MDA level, C GSH content, D CAT activity, and E caspase-3.Where EC, Ehrlich carcinoma; CuNPs, copper nanoparticles, and R, low dose gamma radiation.Data were represented by mean ± SD (n = 6).Statistically significant differ-

Fig. 7 Table 2 Fig. 8
Fig. 7 CuNPs and/or low dose γ-radiation exposure downregulated some oncogenes presented in A NF-κB, B p38 MAPK, and C cyclin D1 genes expression in tumor tissues.Where EC, Ehrlich carcinoma; CuNPs, copper nanoparticles; and R, gamma radiation.Data were represented by mean ± SD (n = 6).The levels of genes transcription were determined using qrt-PCR.Values are given as mean ± SD (n = 6).Statistically significant differences were assessed by a oneway ANOVA followed by post hoc test.Data were considered significant at p ≤ 0.05.Where a, significance compared to control; b, significance compared to EC; c, significance compared to EC/CuNPs; d, significance compared to EC/R; e, significance compared to EC/ CuNPs/R